![Statistical controversies in clinical research: building the bridge to phase II—efficacy estimation in dose-expansion cohorts - Annals of Oncology Statistical controversies in clinical research: building the bridge to phase II—efficacy estimation in dose-expansion cohorts - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/82fa966d-615e-4d55-8471-e99a0da048e0/gr1.jpg)
Statistical controversies in clinical research: building the bridge to phase II—efficacy estimation in dose-expansion cohorts - Annals of Oncology
![Rethinking pragmatic randomised controlled trials: introducing the “cohort multiple randomised controlled trial” design | The BMJ Rethinking pragmatic randomised controlled trials: introducing the “cohort multiple randomised controlled trial” design | The BMJ](https://www.bmj.com/content/bmj/340/bmj.c1066/F1.large.jpg)
Rethinking pragmatic randomised controlled trials: introducing the “cohort multiple randomised controlled trial” design | The BMJ
![The trials within cohorts design facilitated efficient patient enrollment and generalizability in oncology setting - Journal of Clinical Epidemiology The trials within cohorts design facilitated efficient patient enrollment and generalizability in oncology setting - Journal of Clinical Epidemiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2255479b-05b2-4ec5-b478-a97d7f9a0836/gr1.jpg)
The trials within cohorts design facilitated efficient patient enrollment and generalizability in oncology setting - Journal of Clinical Epidemiology
![Summary of in silico clinical trial platform. a) Individual in silico... | Download Scientific Diagram Summary of in silico clinical trial platform. a) Individual in silico... | Download Scientific Diagram](https://www.researchgate.net/publication/337572809/figure/fig2/AS:834612716638209@1575998586392/Summary-of-in-silico-clinical-trial-platform-a-Individual-in-silico-patient-parameter.png)
Summary of in silico clinical trial platform. a) Individual in silico... | Download Scientific Diagram
![It is time to move to alternative clinical trial designs: Reconsidering the holy grail of trial methodology - Multiple Sclerosis and Related Disorders It is time to move to alternative clinical trial designs: Reconsidering the holy grail of trial methodology - Multiple Sclerosis and Related Disorders](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/62310d4a-7a8d-4bf0-af57-7701394c4504/gr1_lrg.jpg)
It is time to move to alternative clinical trial designs: Reconsidering the holy grail of trial methodology - Multiple Sclerosis and Related Disorders
![Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment - The Lancet Oncology Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/73f2df0d-0edd-4eba-a066-3225d572b5a7/gr1.jpg)
Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment - The Lancet Oncology
![Characteristics of the clinical trial and registry-based cohort studies | Download Scientific Diagram Characteristics of the clinical trial and registry-based cohort studies | Download Scientific Diagram](https://www.researchgate.net/publication/303947931/figure/tbl1/AS:956682817511425@1605102366900/Characteristics-of-the-clinical-trial-and-registry-based-cohort-studies.png)
Characteristics of the clinical trial and registry-based cohort studies | Download Scientific Diagram
![Association between outcome disparities and pragmatic features related to clinical trial and real-world settings in nasopharyngeal carcinoma: A population-based retrospective cohort study, 2006–2016 - Radiotherapy and Oncology Association between outcome disparities and pragmatic features related to clinical trial and real-world settings in nasopharyngeal carcinoma: A population-based retrospective cohort study, 2006–2016 - Radiotherapy and Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/bc03d527-755e-44e9-9b70-c7bc66ce7596/gr1.jpg)